Four students to receive SUNY Chancellor's Awards

Four Cornell seniors have been selected to receive the 2020 State University of New York Chancellor’s Award for Student Excellence.

Weill Cornell doctor creates epidemic modeling tool

Mathematical modeling by Weill Cornell Medicine is helping to guide New York state and New York City leaders as they make decisions that could affect the trajectory of the COVID-19 pandemic.

TeleTown Hall: building treatment capacity in pandemic

With lives and livelihoods on pause due to COVID-19, Cornell’s Institute of Politics and Global Affairs hosted a TeleTown Hall April 8 to explore a potential timeline for treatment.

Therapies show knockout potential for rare, deadly liver cancer

A new study identifies some of the most critical genes that may drive a rare but deadly liver cancer, providing a road map for developing drugs that target those genes.

Telemedicine training proves vital during COVID-19 crisis

As hospitals and emergency departments urge more patients to stay home to avoid exposing themselves to COVID-19, patient care is moving to “telemedicine,” using web-based video and audio technology.

(Virtual) Things to Do, April 10-17, 2020

Virtual events and online Cornell resources include a special organ performance, and workshops on workplace health and safety, continuing community-engaged projects and new immigration policy changes.

Snail mail to Wi-Fi: Cornell’s history of remote instruction

The university beginning online classes for the remainder of the semester continues a long history of remote instruction. Liberty Hyde Bailey and Martha Van Rensselaer designed Cornell’s first correspondence courses in 1896 and 1900, respectively.

A virtual celebration for Match Day 2020

While the traditional in-person Match Day celebration hosted on Weill Cornell Medicine’s campus was canceled due to COVID-19, fourth-year graduating students found creative ways to celebrate their accomplishments.

Researchers seek universal treatments to impede coronavirus

New research from a team of Cornell collaborators points to a possible target for antiviral treatment for COVID-19.